Preparation of mitoxantrone nano-drug and application of mitoxantrone nano-drug in targeted therapy of pancreatic cancer

The invention relates to preparation of a mitoxantrone nano-drug and application of the mitoxantrone nano-drug in targeted therapy of pancreatic cancer, and belongs to the technical field of biological medicines. Comprising the following steps: adding a mitoxantrone hydrochloride solution into a sodium hyaluronate solution, dialyzing and freeze-drying to obtain mitoxantrone-hyaluronic acid nano-drug powder; the mitoxantrone and the hyaluronic acid are combined to form the mitoxantrone-hyaluronic acid nano targeting drug. The invention provides an application of a mitoxantrone-hyaluronic acid nano-drug in preparation of a pancreatic cancer treatment drug. The mitoxantrone-hyaluronic acid nano-drug has an obvious inhibition effect on pancreatic tumors; the compound has a CD44 receptor targeting property, can effectively reduce the drug toxicity, and enhances the treatment effect on pancreatic cancer tumors at the same time..

Medienart:

Patent

Erscheinungsjahr:

2023

Erschienen:

2023

Enthalten in:

Europäisches Patentamt - (2023) vom: 07. Nov. Zur Gesamtaufnahme - year:2023

Sprache:

Englisch

Beteiligte Personen:

SHI YUXIN [VerfasserIn]
LIU FENGJUN [VerfasserIn]
CHEN TIANYOU [VerfasserIn]
XU ZHIYANG [VerfasserIn]
SHI NANNAN [VerfasserIn]
LIU XIAOYU [VerfasserIn]
TANG YIDAN [VerfasserIn]
ZHOU SU [VerfasserIn]

Links:

Volltext [kostenfrei]

Themen:

Sonstige Themen:
615
A61K: Preparations for medical, dental, or toilet purpose (...)
A61P: Specific therapeutic activity of chemical compounds (...)
B82Y: Specific uses or applications of nanostructures; me (...)
che
phy
tec

Anmerkungen:

Source: www.epo.org (no modifications made), First posted: 2023-11-07, Last update posted on www.tib.eu: 2024-02-05, Last updated: 2024-02-09

Patentnummer:

CN116999575

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

EPA019114699